Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

The latest on manufacturing and potential treatments for COVID-19 with news from Novartis, the National Institutes of Health, Gilead, GSK, Congress, Inovio, and Cipla. News from Novartis, NIH, Gilead, GSK, Congress Novartis Discontinues Trial of...

A roundup of news from Japan (Takeda), the Netherlands (Gilead Sciences) and the US (GSK, Amarin, Apotex). Japan Takeda Receives FDA Warning Letter Takeda has received a Warning Letter from the US Food and Drug Administration (FDA) for GMP...

Sanofi plans to invest EUR 610 million ($685 million) to create a new production site and research center for vaccines in France, including to allow it to respond to future pandemic risks. In keeping with a corporate strategy announced last...

The latest on manufacturing and potential treatments for COVID-19 with news from Lilly, Gilead, Dr. Reddy’s, Daiichi Sankyo, BioNTech, CureVac, Novavax and others. News from Lilly, Dr. Reddy’s, Gilead, Daiichi Sankyo Lilly Begins Phase III Trial...

Five companies—Teva Pharmaceuticals USA, Lupin, Apotex, Anmeal Pharmaceuticals and Marksans Pharma—are voluntarily recalling in the US select lots of metformin extended-release formulations, a drug to treat Type 2 diabetes, due to evaluated levels...

AbbVie and Genmab, a biopharmaceutical company specializing in antibody therapeutics for treating cancer, have signed a broad collaboration agreement, worth up to $3.9 billion ($750 million up front with the potential to earn $3.15 billion in...

A roundup of news from Denmark (Lundbeck), Japan (Takeda), and the US (UCB). Denmark Lundbeck to Cut R&D Staff H. Lundbeck A/S, a Valby, Denmark biopharmaceutical company, is reorganizing its R&D-organization that may result in cut staff...